APAC Radioimmunoassay Market - Industry Trends and Forecast to 2030

Description

List of Tables

Asia-Pacific radioimmunoassay market is projected to register a substantial CAGR of 3.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (China, Japan, India, South Korea, Australia, Indonesia, Philippines, Thailand, Malaysia, Singapore, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific radioimmunoassay market are:

Increase in the demand for error-free and accurate results of high throughput and automated procedures Rise in the technological advancements

Strategic initiatives by market players

Increasing significance of research and development in medical science

Market Players:

The key market players in Asia-Pacific radioimmunoassay market are listed below:

PerkinElmer Inc.

MP BIOMEDICALS

Tecan Trading AG

Merck KGaA

Immuno-Biological Laboratories Co,Ltd.

EUROIMMUN Medizinische Labordiagnostika AG

Beckman Coulter, Inc.

Berthold Technologies GmbH & Co.KG

Hidex Oy.

Abcam plc

1 INTRODUCTION 65

1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF ASIA PACIFIC RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67

2 MARKET SEGMENTATION 71

2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83

3 EXECUTIVE SUMMARY 84

4 PREMIUM INSIGHTS 87

4.1 PESTEL ANALYSIS 88
4.2 PORTYER'S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90

5 INDUSTRY INSIGHTS: 91

6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92

6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94

7 MARKET OVERVIEW 95

7.1 DRIVERS 97
- 7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
- 7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
- 7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
- 7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
- 7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
- 7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
- 7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
- 7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
- 7.4.1 LACK OF SKILLED PROFESSIONALS 103
- 7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103

8 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104

8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
- 8.2.1 KITS 109
- 8.2.2 BUFFER 109
  - 8.2.2.1 SOLUTION 109
  - 8.2.2.2 POWDER 109
- 8.2.3 STANDARD CONCENTRATES 110
- 8.2.4 PRECIPITATING REAGENTS 110
- 8.2.5 RADIOISOTOPES 110
  - 8.2.5.1 BETA EMITTERS 110
    - 8.2.5.1.1 TRITIUM 110
    - 8.2.5.1.2 CARBON-14 111
  - 8.2.5.2 GAMMA EMITTERS 111
    - 8.2.5.2.1 IODINE-125 111
    - 8.2.5.2.2 CHROMIUM-51 111
    - 8.2.5.2.3 COBALT-57 111
- 8.2.6 ANTIBODY/ANTISERUM 112
  - 8.2.6.1 POLYCLONAL 112
  - 8.2.6.2 MONOCLONAL 112
- 8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113

9 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION 114

9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
- 9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
- 9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
- 9.3.1 INFECTIOUS DISEASE TESTING 120
  - 9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
  - 9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
- 9.3.2 ALLERGY TESTING 121
  - 9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
- 9.3.3 ONCOLOGY TESTING 121
  - 9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.4 ENDOCRINE TESTING 122
  - 9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
  - 9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.5 TOXICOLOGY TESTING 123
  - 9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
  - 9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
- 9.3.6 AUTOIMMUNE DISEASE TESTING 123
  - 9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
  - 9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
- 9.3.7 OTHER DISEASE TESTING 124

10 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER 125

10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132

11 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133

11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140

12 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY REGION 141

12.1 ASIA-PACIFIC 142
- 12.1.1 CHINA 154
- 12.1.2 JAPAN 161
- 12.1.3 INDIA 168
- 12.1.4 SOUTH KOREA 176
- 12.1.5 AUSTRALIA 184
- 12.1.6 INDONESIA 192
- 12.1.7 PHILIPPINES 199
- 12.1.8 THAILAND 207
- 12.1.9 MALAYSIA 215
- 12.1.10 SINGAPORE 222
- 12.1.11 REST OF ASIA-PACIFIC 230

13 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 231

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 231

14 SWOT ANALYSIS 232

15 COMPANY PROFILE 233

15.1 PERKINELMER INC. 233
- 15.1.1 COMPANY SNAPSHOT 233
- 15.1.2 REVENUE ANALYSIS 233
- 15.1.3 COMPANY SHARE ANALYSIS 234
- 15.1.4 PRODUCT PORTFOLIO 234
- 15.1.4 RECENT DEVELOPMENT 235
15.2 MERCK KGAA 236
- 15.2.1 COMPANY SNAPSHOT 236
- 15.2.2 REVENUE ANALYSIS 236
- 15.2.3 COMPANY SHARE ANALYSIS 237
- 15.2.4 PRODUCT PORTFOLIO 237
- 15.2.5 RECENT DEVELOPMENTS 237
15.3 BECKMAN COULTER, INC. 239
- 15.3.1 COMPANY SNAPSHOT 239
- 15.3.2 COMPANY SHARE ANALYSIS 239
- 15.3.3 PRODUCT PORTFOLIO 239
- 15.3.4 RECENT DEVELOPMENT 240
15.4 ABCAM PLC 241
- 15.4.1 COMPANY SNAPSHOT 241
- 15.4.2 REVENUE ANALYSIS 241
- 15.4.3 COMPANY SHARE ANALYSIS 242
- 15.4.4 PRODUCT PORTFOLIO 242
- 15.4.5 RECENT DEVELOPMENT 242
15.5 TECAN TRADING AG 243
- 15.5.1 COMPANY SNAPSHOT 243
- 15.5.2 REVENUE ANALYSIS 243
- 15.5.3 COMPANY SHARE ANALYSIS 244
- 15.5.4 PRODUCT PORTFOLIO 244
- 15.5.5 RECENT DEVELOPMENT 245
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 246
- 15.6.1 COMPANY SNAPSHOT 246
- 15.6.2 PRODUCT PORTFOLIO 246
- 15.6.3 RECENT DEVELOPMENTS 246
15.7 DEMEDITEC DIAGNOSTICS GMBH 247
- 15.7.1 COMPANY SNAPSHOT 247
- 15.7.2 PRODUCT PORTFOLIO 247
- 15.7.3 RECENT DEVELOPMENTS 248
15.8 DIASOURCE 249
- 15.8.1 COMPANY SNAPSHOT 249
- 15.8.2 PRODUCT PORTFOLIO 249
- 15.8.3 RECENT DEVELOPMENT 249
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 250
- 15.9.1 COMPANY SNAPSHOT 250
- 15.9.2 PRODUCT PORTFOLIO 250
- 15.9.3 RECENT DEVELOPMENTS 250
15.10 HIDEX OY 252
- 15.10.1 COMPANY SNAPSHOT 252
- 15.10.2 PRODUCT PORTFOLIO 252
- 15.10.3 RECENT DEVELOPMENTS 252
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 253
- 15.11.1 COMPANY SNAPSHOT 253
- 15.11.2 PRODUCT PORTFOLIO 253
- 15.11.3 RECENT DEVELOPMENT 255
15.12 INSTITUTE OF ISOTOPES 256
- 15.12.1 COMPANY SNAPSHOT 256
- 15.12.2 PRODUCT PORTFOLIO 256
- 15.12.3 RECENT DEVELOPMENTS 257
15.13 KAMIYA BIOMEDICAL COMPANY 258
- 15.13.1 COMPANY SNAPSHOT 258
- 15.13.2 PRODUCT PORTFOLIO 258
- 15.13.3 RECENT DEVELOPMENTS 258
15.14 MP BIOMEDICALS 259
- 15.14.1 COMPANY SNAPSHOT 259
- 15.14.2 PRODUCT PORTFOLIO 259
- 15.14.3 RECENT DEVELOPMENTS 260
15.15 MYBIOSOURCE.COM. 261
- 15.15.1 COMPANY SNAPSHOT 261
- 15.15.2 PRODUCT PORTFOLIO 261
- 15.15.3 RECENT DEVELOPMENT 261

16 QUESTIONNAIRE 262

17 RELATED REPORTS 265

LIST OF TABLES

TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 58
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 63
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 64
TABLE 4 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 5 ASIA PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 6 ASIA PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 7 ASIA PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 8 ASIA PACIFIC RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 9 ASIA PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 10 ASIA PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 11 ASIA PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 77
TABLE 12 ASIA PACIFIC RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 13 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 82
TABLE 14 ASIA PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 15 ASIA PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 83
TABLE 16 ASIA PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 17 ASIA PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 18 ASIA PACIFIC INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 85
TABLE 19 ASIA PACIFIC ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 20 ASIA PACIFIC ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 ASIA PACIFIC ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
TABLE 22 ASIA PACIFIC TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 88
TABLE 23 ASIA PACIFIC AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 88
TABLE 24 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 93
TABLE 25 ASIA PACIFIC HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 26 ASIA PACIFIC CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 27 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 ASIA PACIFIC PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 29 ASIA PACIFIC CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 30 ASIA PACIFIC OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 ASIA PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 101
TABLE 32 ASIA PACIFIC DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 ASIA PACIFIC ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 34 ASIA PACIFIC THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 35 ASIA PACIFIC OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 36 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 111
TABLE 37 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 38 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 39 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 40 ASIA-PACIFIC RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 41 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 42 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 43 ASIA-PACIFIC BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 44 ASIA-PACIFIC RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 45 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 46 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 47 ASIA-PACIFIC BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 48 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 49 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 50 ASIA-PACIFIC GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 51 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 114
TABLE 52 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 115
TABLE 53 ASIA-PACIFIC ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 115
TABLE 54 ASIA-PACIFIC RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 55 ASIA-PACIFIC RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 56 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 57 ASIA-PACIFIC SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 58 ASIA-PACIFIC CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 59 ASIA-PACIFIC INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 ASIA-PACIFIC ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 61 ASIA-PACIFIC ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 62 ASIA-PACIFIC ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 63 ASIA-PACIFIC TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 64 ASIA-PACIFIC AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 65 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 66 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 67 CHINA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 69 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 70 CHINA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 119
TABLE 71 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 72 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 73 CHINA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 74 CHINA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 75 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 76 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 77 CHINA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 78 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 79 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 80 CHINA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 81 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 122
TABLE 82 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 122
TABLE 83 CHINA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 122
TABLE 84 CHINA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 85 CHINA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 86 CHINA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 122
TABLE 87 CHINA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 88 CHINA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 89 CHINA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 90 CHINA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 91 CHINA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 92 CHINA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 93 CHINA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 124
TABLE 94 CHINA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 95 CHINA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 96 CHINA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 97 JAPAN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 98 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 99 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 126
TABLE 100 JAPAN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 126
TABLE 101 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 102 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 127
TABLE 103 JAPAN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 127
TABLE 104 JAPAN RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 105 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 106 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 107 JAPAN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 108 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 109 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 110 JAPAN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 111 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 129
TABLE 112 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 129
TABLE 113 JAPAN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 129
TABLE 114 JAPAN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 115 JAPAN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 116 JAPAN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 117 JAPAN SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 118 JAPAN CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 119 JAPAN INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 120 JAPAN ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 121 JAPAN ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 122 JAPAN ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 123 JAPAN TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 131
TABLE 124 JAPAN AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 125 JAPAN RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 132
TABLE 126 JAPAN RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
TABLE 127 INDIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 128 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 129 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 133
TABLE 130 INDIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 133
TABLE 131 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 132 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 134
TABLE 133 INDIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 134
TABLE 134 INDIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 135 INDIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134

TABLE 136 INDIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 135
TABLE 137 INDIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 138 INDIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 139 INDIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 135
TABLE 140 INDIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 141 INDIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 136
TABLE 142 INDIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 136
TABLE 143 INDIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 136
TABLE 144 INDIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 145 INDIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 136
TABLE 146 INDIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 147 INDIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 148 INDIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
TABLE 149 INDIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 150 INDIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 151 INDIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 152 INDIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 153 INDIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 139
TABLE 154 INDIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 155 INDIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 156 INDIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 140
TABLE 157 SOUTH KOREA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 158 SOUTH KOREA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 159 SOUTH KOREA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 141
TABLE 160 SOUTH KOREA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 141
TABLE 161 SOUTH KOREA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 162 SOUTH KOREA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 142
TABLE 163 SOUTH KOREA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 142
TABLE 164 SOUTH KOREA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 165 SOUTH KOREA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 166 SOUTH KOREA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 143
TABLE 167 SOUTH KOREA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 143
TABLE 168 SOUTH KOREA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 169 SOUTH KOREA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 143
TABLE 170 SOUTH KOREA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 143
TABLE 171 SOUTH KOREA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 144
TABLE 172 SOUTH KOREA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 144
TABLE 173 SOUTH KOREA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 144
TABLE 174 SOUTH KOREA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 144
TABLE 175 SOUTH KOREA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 144
TABLE 176 SOUTH KOREA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 177 SOUTH KOREA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 178 SOUTH KOREA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 179 SOUTH KOREA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 180 SOUTH KOREA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 181 SOUTH KOREA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 182 SOUTH KOREA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 183 SOUTH KOREA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 147
TABLE 184 SOUTH KOREA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 185 SOUTH KOREA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 148
TABLE 186 SOUTH KOREA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
TABLE 187 AUSTRALIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 188 AUSTRALIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 189 AUSTRALIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 149
TABLE 190 AUSTRALIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 149
TABLE 191 AUSTRALIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 192 AUSTRALIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 150
TABLE 193 AUSTRALIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 150
TABLE 194 AUSTRALIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 195 AUSTRALIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 196 AUSTRALIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 151
TABLE 197 AUSTRALIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 151
TABLE 198 AUSTRALIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 199 AUSTRALIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 151
TABLE 200 AUSTRALIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 151
TABLE 201 AUSTRALIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 152
TABLE 202 AUSTRALIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 152
TABLE 203 AUSTRALIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 152
TABLE 204 AUSTRALIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 152
TABLE 205 AUSTRALIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 152
TABLE 206 AUSTRALIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 207 AUSTRALIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 208 AUSTRALIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 153
TABLE 209 AUSTRALIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 210 AUSTRALIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 211 AUSTRALIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 212 AUSTRALIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 213 AUSTRALIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 155
TABLE 214 AUSTRALIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 215 AUSTRALIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 156
TABLE 216 AUSTRALIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 156
TABLE 217 INDONESIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 218 INDONESIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 219 INDONESIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 157
TABLE 220 INDONESIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 157
TABLE 221 INDONESIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
TABLE 222 INDONESIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 158
TABLE 223 INDONESIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 158
TABLE 224 INDONESIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
TABLE 225 INDONESIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
TABLE 226 INDONESIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 159
TABLE 227 INDONESIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 159
TABLE 228 INDONESIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 229 INDONESIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 159
TABLE 230 INDONESIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 159
TABLE 231 INDONESIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 160
TABLE 232 INDONESIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 160
TABLE 233 INDONESIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 160
TABLE 234 INDONESIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 160
TABLE 235 INDONESIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 160
TABLE 236 INDONESIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 237 INDONESIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 238 INDONESIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 161
TABLE 239 INDONESIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 240 INDONESIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 241 INDONESIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 242 INDONESIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 243 INDONESIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 162
TABLE 244 INDONESIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 245 INDONESIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 163
TABLE 246 INDONESIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 247 PHILIPPINES RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 248 PHILIPPINES RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 249 PHILIPPINES RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 164
TABLE 250 PHILIPPINES RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 164
TABLE 251 PHILIPPINES BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 252 PHILIPPINES BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 165
TABLE 253 PHILIPPINES BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 165
TABLE 254 PHILIPPINES RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 255 PHILIPPINES BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 256 PHILIPPINES BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 166
TABLE 257 PHILIPPINES BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 166
TABLE 258 PHILIPPINES GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
TABLE 259 PHILIPPINES GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 166
TABLE 260 PHILIPPINES GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 166
TABLE 261 PHILIPPINES ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 167
TABLE 262 PHILIPPINES ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 167

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: SEGMENTATION 35
FIGURE 2 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION 38
FIGURE 3 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: DROC ANALYSIS 39
FIGURE 4 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 40
FIGURE 5 ASIA PACIFIC RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS 40
FIGURE 6 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS 42
FIGURE 7 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID 43
FIGURE 8 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID 45
FIGURE 9 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS 46
FIGURE 10 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: SEGMENTATION 50
FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE ASIA PACIFIC RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD 51
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC RADIOIMMUNOASSAY MARKET IN 2023 & 2030 51
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC RADIOIMMUNOASSAY MARKET 60
FIGURE 14 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022 69
FIGURE 15 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 70
FIGURE 16 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 70
FIGURE 17 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE 71
FIGURE 18 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022 79
FIGURE 19 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 80
FIGURE 20 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030) 80
FIGURE 21 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE 81
FIGURE 22 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY END USER, 2022 90
FIGURE 23 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION) 91
FIGURE 24 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030) 91
FIGURE 25 ASIA PACIFIC RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE 92
FIGURE 26 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022 98
FIGURE 27 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 99
FIGURE 28 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 99
FIGURE 29 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 100
FIGURE 30 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 107
FIGURE 31 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 108
FIGURE 32 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 108
FIGURE 33 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 109
FIGURE 34 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 109
FIGURE 35 ASIA PACIFIC RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 195